Novonesis (Novozymes) NOVONESIS B ORD SHS
Novonesis (Novozymes) NOVONESIS B.../ DK0060336014 /
0Q4U
2024-05-02 4:54:47 PM
|
Chg.
+3.35
|
Volume |
Bid4:55:05 PM |
Ask4:55:05 PM |
Market Capitalization |
Dividend Y. |
P/E Ratio |
389.00DKK
|
+0.87%
|
9,441 Turnover: 3.18 mill. |
-Bid Size: - |
-Ask Size: - |
108.51 bill.DKK |
1.54% |
29.29 |
Business description
Novozymes is the world leader in biological solutions. As the world’s largest provider of enzyme and microbial technologies, the company´s bioinnovation enables higher agricultural yields, low-temperature washing, energy-efficient production, renewable fuel and many other benefits.
Management board & Supervisory board
CEO |
Ester Baiget |
Management board |
Rainer Lehmann, Amy Byrick, Anders Lund, Claus Crone Fuglsang, Graziela Chaluppe dos Santos Malucelli, Morten Enggaard Rasmussen, Tina Sejersgård Fanø |
Supervisory board |
Cees de Jong, Andreas Hentze Knudsen, Anne Breum, Cees de Jong, Heine Dalsgaard, Jens Øbro, Kasim Kutay, Kim Stratton, Mathias Uhlén, Preben Nielsen, Sharon James |
Company data
Name: |
Novozymes A.S |
Address: |
Krogshoejvej 36,DK-2880 Bagsvaerd |
Phone: |
+45-44-460000 |
Fax: |
- |
E-mail: |
-
|
Internet: |
www.novozymes.com/ |
Industry: |
Biotechnology |
Sector: |
Biotechnology |
Sub sector: |
Biotechnology |
End of financial year: |
12-31 |
Free Float: |
74.50% |
IPO date: |
2000-11-20 |
Company calendar
CW 18 | 2024-05-03
Interim Report 1st Quarter/3 Months
|
CW 18 | 2024-05-03
Dividend Payment
|
CW 35 | 2024-08-28
Interim Report 2nd Quarter/6 Months
|
CW 45 | 2024-11-07
Interim Report 3rd Quarter/9 Months
|
CW 9 | 2025-02-26
4th Quarter/Annual Report
|